Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities
Objectives: Diabetes mellitus is characterised by progressive β-cell destruction and loss of function, or loss of ability of tissues to respond to insulin. Daily subcutaneous insulin injection is standard management for people with diabetes, although patient compliance is hard to achieve due to the...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/16226 |